Asymptomatic HIV testing in Negrar di Valpolicella

Find health labs to test for Asymptomatic HIV in Negrar di Valpolicella and compare all offers by prices and services.

Tests that cover Asymptomatic HIV

HIV Test
test epatite B, epatite C, HIV con autoprelievo by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€60.00

€57.00 with our promocode

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Lorenzo Fava, 4/B 37139 Verona (VR)

6.9 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Brunelleschi, 1B 37138 Verona (VR)

6.9 km

Unverified

See Details

HIV Test by Laboratorio Lifebrain

Via Giovanni Pascoli, 4 c/o JoLab 37013 Affi (VR)

8.1 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Legnago, 126 37134 Verona (VR)

6.9 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Viale Francesco Agello, 1, Rivoltella, 25015 Desenzano del Garda BS

19.7 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Pellizzari, 125 c/o Centro Medico Città di Arzignano 36071 Arzignano (VI)

19.1 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Cesare Battisti, 23 37051 Bovolone (VR)

20.8 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Viale dell'Industria, 93 36070 Trissino (VI)

21.3 km

Unverified

See Details

HIV Test by Laboratorio Lifebrain

Via Giovanni XXIII, 18 38065 Mori (TN)

22.3 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Pesa, 19 36063 Montebello Vicentino (VI)

22.3 km

Unverified

See Details

Asymptomatic HIV - symptoms and how to test

The second stage of HIV/AIDS involves infection without symptoms. At this time, HIV infection shows no visible symptoms. Patients often seek medical treatment due to symptoms; therefore, asymptomatic infections frequently go undetected. According to an estimate, around 10-60 % of individuals with early HIV infection will not experience symptoms. Patients who are asymptomatic but have HIV infection might benefit from therapies to lower their risk of clinical events and disease transmission if tested and found to have the virus.